Africa CDC

The summit concluded with stakeholders committing to strengthen surveillance systems, build diagnostic capacity, and expand access to treatment throughout the continent.

The partnership will focus on joint initiatives addressing antimicrobial resistance, vaccine-preventable diseases, and emerging health threats.

The agreement establishes a structured framework for tackling emerging and re-emerging public health threats while strengthening pandemic prevention and preparedness systems.

The partnership will also support digital transformation, institutional capacity-building, and integrated health systems that promote sustainability and national ownership.

The new infrastructure enables the organization to procure, store, and rapidly deploy critical medical supplies when outbreaks threaten African communities.

The newly launched CDR tackles this fundamental challenge by establishing a secure, interoperable platform that brings together surveillance information, laboratory results, and programme data from both national and regional systems.

The Democratic Republic of the Congo bore the heaviest burden, accounting for 96% of reported cases and 97% of deaths.

The partnership enables Africa CDC to reinforce its central role in advancing continental priorities, including its 2023–2027 Strategic Plan and the Africa Health Security and Sovereignty (AHSS) agenda.

The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.

The study analysed more than 187,000 laboratory test results from 205 laboratories located in 14 African countries, including Nigeria, using samples collected between 2016 and 2019.